Molecular Nodal Restaging Based on CEACAM5, FGFR2b and PTPN11 Expression Adds No Relevant Clinical Information in Resected Non-Small Cell Lung Cancer

References

• Rusch VW, Hawes D, Decker PA, et al. Occult metastases in lymph nodes predict survival in resectable non-small-cell lung cancer: report of the ACOSOG Z0040 trial. JCO. 2011;29(32):4313–4319. doi:https://doi.org/10.1200/JCO.2011.35.2500.
   PubMed Web of Science ®Google Scholar
• Kubuschok B, Passlick B, Izbicki JR, Thetter O, Pantel K. Disseminated tumor cells in lymph nodes as a determinant for survival in surgically resected non-small-cell lung cancer. JCO. 1999;17(1):19–24. http://www.ncbi.nlm.nih.gov/pubmed/10458213. Accessed July 31, 2014. doi:https://doi.org/10.1200/JCO.1999.17.1.19.
   PubMed Web of Science ®Google Scholar
• Li SH, Wang Z, Liu XY, Liu FY. Gene diagnosis and prognostic significance of lymph node micrometastasis after complete resection of histologically node-negative non-small cell lung cancer. World J Surg. 2008;32(8):1651–1656. doi:https://doi.org/10.1007/s00268-008-9560-6.
   PubMed Web of Science ®Google Scholar
• Li J, Li Z-N, Yu L-C, et al. Gene diagnosis of micrometastases in regional lymph nodes of patients with stage I non-small cell lung cancer: impact on staging and prognosis. Clin Transl Oncol. 2013;15(11):882–888. doi:https://doi.org/10.1007/s12094-013-1017-1.
   PubMed Web of Science ®Google Scholar
• Benlloch S, Galbis-Caravajal JM, Alenda C, et al. Expression of molecular markers in mediastinal nodes from resected stage I non-small-cell lung cancer (NSCLC): prognostic impact and potential role as markers of occult micrometastases. Ann Oncol. 2009;20(1):91–97. doi:https://doi.org/10.1093/annonc/mdn538.
   PubMed Web of Science ®Google Scholar
• Nosotti M, Palleschi A, Rosso L, et al. Lymph node micrometastases detected by carcinoembryonic antigen mRNA affect long-term survival and disease-free interval in early-stage lung cancer patients. Oncol Lett. 2012;4(5):1140–1144. doi:https://doi.org/10.3892/ol.2012.880.
   PubMed Web of Science ®Google Scholar
• Harden SV, Tokumaru Y, Westra WH, et al. Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients. Clin Cancer Res. 2003;9(4):1370–1375.
   PubMed Web of Science ®Google Scholar
• Martin LW, D'Cunha J, Wang X, et al. Detection of occult micrometastases in patients with clinical Stage I non-small-cell lung cancer: a prospective analysis of mature results of CALGB 9761 (Alliance) ). J Clin Oncol. 2016;34(13):1484–1491. doi:https://doi.org/10.1200/JCO.2015.63.4543.
   PubMed Web of Science ®Google Scholar
• Ahrendt SA, Yang SC, Wu L, et al. Molecular assessment of lymph nodes in patients with resected stage I non-small cell lung cancer: preliminary results of a prospective study. J Thorac Cardiovasc Surg. 2002;123(3):466–466. doi:https://doi.org/10.1067/mtc.2002.120343.
   PubMed Web of Science ®Google Scholar
• Xi L, Coello MC, Litle VR, et al. A combination of molecular markers accurately detects lymph node metastasis in non-small cell lung cancer patients. Clin Cancer Res. 2006;12(8):2484–2491. doi:https://doi.org/10.1158/1078-0432.CCR-05-2037.
   PubMed Web of Science ®Google Scholar
• Borczuk AC, Gorenstein L, Walter KL, Assaad AA, Wang L, Powell CA. Non-small-cell lung cancer molecular signatures recapitulate lung developmental pathways. Am J Pathol. 2003;163(5):1949–1960. doi:https://doi.org/10.1016/S0002-9440(10)63553-5.
   PubMed Web of Science ®Google Scholar
• Navarro A, Marrades RM, Viñolas N, et al. MicroRNAs expressed during lung cancer development are expressed in human pseudoglandular lung embryogenesis. Oncology. 2009;76(3):162–169. doi:https://doi.org/10.1159/000201569.
   PubMed Web of Science ®Google Scholar
• Warburton D, Bellusci S, De Langhe S, et al. Molecular Mechanisms of Early Lung Specification and Branching Morphogenesis. Pediatr Res. 2005;57(5 Pt 2):26R–37R. Partdoi:https://doi.org/10.1203/01.PDR.0000159570.01327.ED.
   PubMed Web of Science ®Google Scholar
• Cardoso WV, Lu J. Regulation of early lung morphogenesis: questions, facts and controversies. Development. 2006;133(9):1611–1624. doi:https://doi.org/10.1242/dev.02310.
   PubMed Web of Science ®Google Scholar
• Litingtung Y, Lei L, Westphal H, Chiang C. Sonic hedgehog is essential to foregut development. Nat Genet. 1998;20(1):58–61. doi:https://doi.org/10.1038/1717.
   PubMed Web of Science ®Google Scholar
• Nolan T, Hands RE, Bustin SA. Quantification of mRNA using real-time RT-PCR. Nat Protoc. 2006;1(3):1559–1582. doi:https://doi.org/10.1038/nprot.2006.236.
   PubMed Web of Science ®Google Scholar
• Macia I, Moya J, Escobar I, et al. Quality study of a lung cancer committee: study of agreement between preoperative and pathological staging. Eur J Cardiothorac Surg. 2010;37(3):540–545. doi:https://doi.org/10.1016/j.ejcts.2009.07.026
   PubMed Web of Science ®Google Scholar
• Pimpec-Barthes FL, Danel C, Lacave R, et al. Association of CK19 mRNA detection of occult cancer cells in mediastinal lymph nodes in non-small cell lung carcinoma and high risk of early recurrence . Eur J Cancer. 2005;41(2):306–312. doi:https://doi.org/10.1016/j.ejca.2004.09.021.
   PubMed Web of Science ®Google Scholar
• Nosotti M, Falleni M, Palleschi A, et al. Quantitative real-time polymerase chain reaction detection of lymph node lung cancer micrometastasis using carcinoembryonic antigen marker. Chest. 2005;128(3):1539–1544. doi:https://doi.org/10.1378/chest.128.3.1539.
   PubMed Web of Science ®Google Scholar
• Ge MJ, Wu QC, Wang M, Zhang YH, Li LB. Detection of disseminated lung cancer cells in regional lymph nodes by assay of CK19 reverse transcriptase polymerase chain reaction and its clinical significance. J Cancer Res Clin Oncol. 2005;131(10):662–668. doi:https://doi.org/10.1007/s00432-005-0009-0.
   PubMed Web of Science ®Google Scholar
• Vinayanuwattikun C, Chantranuwat P, Sriuranpong V, Mutirangura A. The role of SHP-1 promoter 2 hypermethylation detection of lymph node micrometastasis in resectable stage I non-small cell lung cancer as a prognostic marker of disease recurrence. Int J Clin Oncol. 2014;19(4):592–593. doi:https://doi.org/10.1007/s10147-013-0590-1.
   Web of Science ®Google Scholar
• Brock MV, Hooker CM, Ota-Machida E, et al. DNA Methylation Markers and Early Recurrence in Stage I Lung Cancer. N Engl J Med. 2008;358(11):1118–1128. doi:https://doi.org/10.1056/NEJMoa0706550.
   PubMed Web of Science ®Google Scholar
• Dai C-H, Li J, Yu L-C, Li X-Q, Shi S-B, Wu J-R. Molecular diagnosis and prognostic significance of lymph node micrometastasis in patients with histologically node-negative non-small cell lung cancer. Tumour Biol. 2013;34(2):1245–1253. doi:https://doi.org/10.1007/s13277-013-0667-5.
   PubMedGoogle Scholar
• Qiu Y, Yang H, Chen H, et al. Detection of CEA mRNA, p53 and AE1/AE3 in haematoxylin-eosin-negative lymph nodes of early-stage non-small cell lung cancer may improve veracity of N staging and indicate prognosis. Jpn J Clin Oncol. 2010;40(2):146–152. doi:https://doi.org/10.1093/jjco/hyp144.
   PubMed Web of Science ®Google Scholar
• Nwogu CE, Yendamuri S, Tan W, et al. Lung cancer lymph node micrometastasis detection using real-time polymerase chain reaction: correlation with vascular endothelial growth factor expression. J Thorac Cardiovasc Surg. 2013;145(3):702–707. discussion 707-8. doi:https://doi.org/10.1016/j.jtcvs.2012.12.023.
   PubMed Web of Science ®Google Scholar
• Molina R, Marrades RM, Augé JM, Escudero JM, et al. Assessment of a combined panel of six serum tumor markers for lung cancer. Am J Respir Crit Care Med. 2016;193(4):427–437. doi:https://doi.org/10.1164/rccm.201404-0603OC.
   PubMed Web of Science ®Google Scholar
• Okayama H, Kohno T, Ishii Y, et al. Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas. Cancer Res. 2012;72(1):100–111. doi:https://doi.org/10.1158/0008-5472.CAN-11-1403
   PubMed Web of Science ®Google Scholar
• Li J, Jie H-B, Lei Y, et al. PD-1/SHP-2 Inhibits Tc1/Th1 Phenotypic responses and the activation of T cells in the tumor microenvironment. Cancer Res. 2015;75(3):508–518. doi:https://doi.org/10.1158/0008-5472.CAN-14-1215.
   PubMed Web of Science ®Google Scholar
• Osarogiagbon RU, Ogbata O, Yu X. Number of lymph nodes associated with maximal reduction of long-term mortality risk in pathologic node-negative non-small cell lung cancer. Ann Thorac Surg. 2014;97(2):385–393. doi:https://doi.org/10.1016/j.athoracsur.2013.09.058.
   PubMed Web of Science ®Google Scholar
• D'Cunha J, Corfits AL, Herndon JE, et al. Molecular staging of lung cancer: real-time polymerase chain reaction estimation of lymph node micrometastatic tumor cell burden in stage I non-small cell lung cancer–preliminary results of cancer and leukemia Group B Trial 9761. J Thorac Cardiovasc Surg. 2002;123(3):484–491; discussion 491. doi:https://doi.org/10.1067/mtc.2002.119883.
   PubMed Web of Science ®Google Scholar
• Ren Y, Zhang L, Xie H, et al. Lymph node micrometastasis prognosticates survival for patients with stage 1 bronchogenic adenocarcinoma. Ann Surg Oncol. 2018;25(13):3812–3819. doi:https://doi.org/10.1245/s10434-018-6743-8.
   PubMed Web of Science ®Google Scholar
• Deng XF, Jiang L, Liu QX, et al. Lymph node micrometastases are associated with disease recurrence and poor survival for early-stage non-small cell lung cancer patients: a meta-analysis. J Cardiothorac Surg. 2016;11(1):28. doi:https://doi.org/10.1186/s13019-016-0427-x.
   PubMed Web of Science ®Google Scholar
• Marchevsky AM, Gupta R, Kusuanco D, Mirocha J, McKenna Jr RJ. The presence of isolated tumor cells and micrometastases in the intrathoracic lymph nodes of patients with lung cancer is not associated with decreased survival. Hum Pathol. 2010;41(11):1536–1543. doi:https://doi.org/10.1016/j.humpath.2010.04.006.
   PubMed Web of Science ®Google Scholar
• Carretta A. Clinical value of nodal micrometastases in patients with non-small cell lung cancer: time for reconsideration? J Thorac Dis. 2016;8(12):E1755–e1758. doi:https://doi.org/10.21037/jtd.2016.12.83.
   PubMed Web of Science ®Google Scholar
• Cerfolio RJ, Maniscalco L, Bryant AS. The treatment of patients with stage IIIA non-small cell lung cancer from N2 disease: who returns to the surgical arena and who survives. Ann Thorac Surg. 2008;86(3):912–920. doi:https://doi.org/10.1016/j.athoracsur.2008.04.073.
   PubMed Web of Science ®Google Scholar